Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2909 (LINC02909, also known as C12orf77) is a human long non-coding RNA gene from the lincRNA subclass. LINC02909 does not encode a protein, and its functional roles remain uncharacterized in the scientific literature as of 2024. Like other lincRNAs, it is presumed to be involved in gene expression regulation, chromatin architecture modulation, and possibly in RNA stabilization or nuclear processes. LINC02909 has not been established as a therapeutic target, nor are there any known drugs or disease-specific associations reported. Information on its biological roles is extrapolated from the general features of lincRNAs, which often act in cell-type specific regulatory mechanisms but are only rarely characterized in detail for individual lincRNA loci[1][3].
null (no drugs target this molecule; for lincRNAs in general, mechanisms include transcriptional interference, chromatin modification, and molecular scaffolding[1])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2909 (LINC02909).